AMGN
Amgen’s (AMGN) Q4 2025 results beat on both lines as the biotech issued 2026 financial...
Amgen press release (AMGN): Q4 Non-GAAP EPS of $5.29 beats by $0.53. Revenue of $9.9B...
Comments (22) vzphotos/iStock Editorial via Getty Images AbbVie (ABBV) has reached a three-year deal with...


